par Piccart-Gebhart, Martine
Référence Annals of oncology, 24, 8, page (1951-1955)
Publication Publié, 2013-08
Référence Annals of oncology, 24, 8, page (1951-1955)
Publication Publié, 2013-08
Article révisé par les pairs
Titre: |
|
Auteur: | Piccart-Gebhart, Martine |
Informations sur la publication: | Annals of oncology, 24, 8, page (1951-1955) |
Statut de publication: | Publié, 2013-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antibodies, Monoclonal, Humanized -- adverse effects -- therapeutic use |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Carcinoma, Non-Small-Cell Lung -- drug therapy -- genetics | |
Colorectal Neoplasms -- drug therapy | |
Female | |
Humans | |
Individualized Medicine -- methods | |
Lung Neoplasms -- drug therapy -- genetics | |
Molecular Targeted Therapy -- adverse effects -- methods | |
Quinazolines -- therapeutic use | |
Receptor, Epidermal Growth Factor -- drug effects -- genetics -- immunology | |
Receptor, ErbB-2 -- drug effects -- immunology | |
Note générale: | SCOPUS: ed.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:doi/10.1093/annonc/mdt260 | |
info:pii/mdt260 | |
info:scp/84881252783 | |
info:pmid/23878113 |